These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30008879)

  • 41. Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells.
    Feng X; Liu H; Zhang Z; Gu Y; Qiu H; He Z
    J Exp Clin Cancer Res; 2017 Sep; 36(1):123. PubMed ID: 28886730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression.
    Zang YS; Zhong YF; Fang Z; Li B; An J
    Cancer Gene Ther; 2012 Nov; 19(11):773-8. PubMed ID: 22996741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased MALAT1 expression contributes to cisplatin resistance in non-small cell lung cancer.
    Cui Y; Li G; Zhang X; Dai F; Zhang R
    Oncol Lett; 2018 Oct; 16(4):4821-4828. PubMed ID: 30250547
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibitory effects of polyphyllins I and VII on human cisplatin-resistant NSCLC via p53 upregulation and CIP2A/AKT/mTOR signaling axis inhibition.
    Feng FF; Cheng P; Sun C; Wang H; Wang W
    Chin J Nat Med; 2019 Oct; 17(10):768-777. PubMed ID: 31703757
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Breviscapine suppresses the growth of non-small cell lung cancer by enhancing microRNA-7 expression.
    Zeng J; Cai S
    J Biosci; 2017 Mar; 42(1):121-129. PubMed ID: 28229971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiosensitizing effects of Cyclocarya paliurus polysaccharide on hypoxic A549 and H520 human non-small cell lung carcinoma cells.
    Zhang F; Fan B; Mao L
    Int J Mol Med; 2019 Oct; 44(4):1233-1242. PubMed ID: 31364726
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-apoptotic brain and reproductive organ-expressed proteins enhance cisplatin resistance in lung cancer cells via the protein kinase B signaling pathway.
    Li Y; Qi K; Zu L; Wang M; Wang Y; Zhou Q
    Thorac Cancer; 2016 Mar; 7(2):190-8. PubMed ID: 27042221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA‑145 inhibits migration and induces apoptosis in human non‑small cell lung cancer cells through regulation of the EGFR/PI3K/AKT signaling pathway.
    Li B; Ding CM; Li YX; Peng JC; Geng N; Qin WW
    Oncol Rep; 2018 Nov; 40(5):2944-2954. PubMed ID: 30226581
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The effects of Tumstatin185-191 on lung adenocarcinoma cell lines and the association with protein kinase B and extracellular regulated protein kinase activation].
    Wang W; Chen P; Li JL; Pei YF; Shuang QC; Liu CH; Cai S; Liu SK; Zhu LY; Zhou R
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Feb; 33(2):123-7. PubMed ID: 20367953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway.
    Jin H; Qiao F; Wang Y; Xu Y; Shang Y
    Oncol Rep; 2015 Nov; 34(5):2782-9. PubMed ID: 26351877
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardamonin inhibits the proliferation and metastasis of non-small-cell lung cancer cells by suppressing the PI3K/Akt/mTOR pathway.
    Zhou X; Zhou R; Li Q; Jie X; Hong J; Zong Y; Dong X; Zhang S; Li Z; Wu G
    Anticancer Drugs; 2019 Mar; 30(3):241-250. PubMed ID: 30640793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNA-124 suppresses proliferation and glycolysis in non-small cell lung cancer cells by targeting AKT-GLUT1/HKII.
    Zhao X; Lu C; Chu W; Zhang B; Zhen Q; Wang R; Zhang Y; Li Z; Lv B; Li H; Liu J
    Tumour Biol; 2017 May; 39(5):1010428317706215. PubMed ID: 28488541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
    Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M
    Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PDCD6 additively cooperates with anti-cancer drugs through activation of NF-κB pathways.
    Park SH; Lee JH; Lee GB; Byun HJ; Kim BR; Park CY; Kim HB; Rho SB
    Cell Signal; 2012 Mar; 24(3):726-33. PubMed ID: 22142513
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens.
    Wu YY; Wu HC; Wu JE; Huang KY; Yang SC; Chen SX; Tsao CJ; Hsu KF; Chen YL; Hong TM
    J Exp Clin Cancer Res; 2019 Jul; 38(1):282. PubMed ID: 31262325
    [TBL] [Abstract][Full Text] [Related]  

  • 56. AKT isoforms have discrete expression in triple negative breast cancers and roles in cisplatin sensitivity.
    Wadhwa B; Paddar M; Khan S; Mir S; A Clarke P; Grabowska AM; Vijay DG; Malik F
    Oncotarget; 2020 Nov; 11(45):4178-4194. PubMed ID: 33227065
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Corrigendum: Regulation of microrna-497-targeting AKT2 influences tumor growth and chemoresistance to cisplatin in lung cancer.
    Wang L; Ji XB; Wang LH; Qiu JG; Zhou FM; Liu WJ; Wan DD; Lin MC; Liu LZ; Zhang JY; Jiang BH
    Front Cell Dev Biol; 2022; 10():1008088. PubMed ID: 36211462
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Erratum: MicroRNA-152 suppresses cisplatin resistance in A549 cells.
    Zhao W; Li H; Yang S; Guo D; Chen J; Miao S; Xin Y; Liang M
    Oncol Lett; 2020 Apr; 19(4):3357. PubMed ID: 32256829
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miR-137: a potential therapeutic target for lung cancer.
    Liu S; Ruan Y; Chen X; He B; Chen Q
    Front Cell Dev Biol; 2024; 12():1427724. PubMed ID: 39247624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. JIB-04, a Pan-Inhibitor of Histone Demethylases, Targets Histone-Lysine-Demethylase-Dependent AKT Pathway, Leading to Cell Cycle Arrest and Inhibition of Cancer Stem-Like Cell Properties in Hepatocellular Carcinoma Cells.
    Lee J; Kim JS; Cho HI; Jo SR; Jang YK
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.